353 related articles for article (PubMed ID: 30741436)
21. A prediction model for skeletal muscle evaluation and computed tomography-defined sarcopenia diagnosis in a predominantly overweight cohort of patients with head and neck cancer.
Vangelov B; Bauer J; Moses D; Smee R
Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):321-328. PubMed ID: 35835910
[TBL] [Abstract][Full Text] [Related]
22. Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults.
Hamaguchi Y; Kaido T; Okumura S; Kobayashi A; Hammad A; Tamai Y; Inagaki N; Uemoto S
Nutrition; 2016; 32(11-12):1200-5. PubMed ID: 27292773
[TBL] [Abstract][Full Text] [Related]
23. CT-measured skeletal muscle mass used to assess frailty in patients with head and neck cancer.
Zwart AT; van der Hoorn A; van Ooijen PMA; Steenbakkers RJHM; de Bock GH; Halmos GB
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1060-1069. PubMed ID: 31134765
[TBL] [Abstract][Full Text] [Related]
24. Muscle Reference Values From Thoracic and Abdominal CT for Sarcopenia Assessment: The Framingham Heart Study.
Tonnesen PE; Mercaldo ND; Tahir I; Dietrich AW; Amayri W; Graur A; Allaire B; Bouxsein ML; Samelson EJ; Kiel DP; Fintelmann FJ
Invest Radiol; 2024 Mar; 59(3):259-270. PubMed ID: 37725490
[TBL] [Abstract][Full Text] [Related]
25. Influence of Contrast Administration on Computed Tomography-Based Analysis of Visceral Adipose and Skeletal Muscle Tissue in Clear Cell Renal Cell Carcinoma.
Paris MT; Furberg HF; Petruzella S; Akin O; Hötker AM; Mourtzakis M
JPEN J Parenter Enteral Nutr; 2018 Sep; 42(7):1148-1155. PubMed ID: 29350403
[TBL] [Abstract][Full Text] [Related]
26. Comparative assessment of abdominal and thigh muscle characteristics using CT-derived images.
de Medeiros GOC; de Sousa IM; Chaves GV; Gonzalez MC; Prado CM; Fayh APT
Nutrition; 2022; 99-100():111654. PubMed ID: 35576877
[TBL] [Abstract][Full Text] [Related]
27. Thoracic skeletal muscle index is effective for CT-defined sarcopenia evaluation in patients with head and neck cancer.
Vangelov B; Smee R; Moses D; Bauer J
Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5583-5594. PubMed ID: 37573279
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis of Sarcopenia Using the L3 Skeletal Muscle Index Estimated From the L1 Skeletal Muscle Index on MR Images in Patients With Cirrhosis.
Xu Z; Yang D; Luo J; Xu H; Jia J; Yang Z
J Magn Reson Imaging; 2023 Nov; 58(5):1569-1578. PubMed ID: 36932680
[TBL] [Abstract][Full Text] [Related]
29. Optimal Cutoff Values of Skeletal Muscle Index to Define Sarcopenia for Prediction of Survival in Patients with Advanced Gastric Cancer.
Nishigori T; Tsunoda S; Obama K; Hisamori S; Hashimoto K; Itatani Y; Okada K; Sakai Y
Ann Surg Oncol; 2018 Nov; 25(12):3596-3603. PubMed ID: 30167910
[TBL] [Abstract][Full Text] [Related]
30. Skeletal Muscle Area on CT: Determination of an Optimal Height Scaling Power and Testing for Mortality Risk Prediction.
Blankemeier L; Yao L; Long J; Reis EP; Lenchik L; Chaudhari AS; Boutin RD
AJR Am J Roentgenol; 2024 Jan; 222(1):e2329889. PubMed ID: 37877596
[No Abstract] [Full Text] [Related]
31. Adverse impact of low skeletal muscle index on the prognosis of hepatocellular carcinoma after hepatic resection.
Yabusaki N; Fujii T; Yamada S; Suzuki K; Sugimoto H; Kanda M; Nakayama G; Koike M; Fujiwara M; Kodera Y
Int J Surg; 2016 Jun; 30():136-42. PubMed ID: 27154615
[TBL] [Abstract][Full Text] [Related]
32. Exploring previously used thresholds for computed tomography-defined low skeletal muscle mass in predicting functional limitations among lung cancer patients.
Timsina SR; Tanomkiat W; Geater SL; Ina N
Thorac Cancer; 2024 Jun; 15(16):1287-1295. PubMed ID: 38666456
[TBL] [Abstract][Full Text] [Related]
33. Psoas muscle index is not representative of skeletal muscle index for evaluating cancer sarcopenia.
Pigneur F; Di Palma M; Raynard B; Guibal A; Cohen F; Daidj N; Aziza R; El Hajjam M; Louis G; Goldwasser F; Deluche E
J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1613-1620. PubMed ID: 37203274
[TBL] [Abstract][Full Text] [Related]
34. Quantifying Sarcopenia Reference Values Using Lumbar and Thoracic Muscle Areas in a Healthy Population.
Derstine BA; Holcombe SA; Goulson RL; Ross BE; Wang NC; Sullivan JA; Su GL; Wang SC
J Nutr Health Aging; 2017; 21(10):180-185. PubMed ID: 29300439
[TBL] [Abstract][Full Text] [Related]
35. Masticatory muscle index for indicating skeletal muscle mass in patients with head and neck cancer.
Chang SW; Tsai YH; Hsu CM; Huang EI; Chang GH; Tsai MS; Tsai YT
PLoS One; 2021; 16(5):e0251455. PubMed ID: 33970954
[TBL] [Abstract][Full Text] [Related]
36. Association between thoracic and third lumbar CT-derived muscle mass and density in Caucasian patients without chronic disease: a proof-of-concept study.
Brath MSG; Sahakyan M; Mark EB; Frøkjær JB; Rasmussen HH; Østergaard LR; Weinreich UM
Eur Radiol Exp; 2023 May; 7(1):26. PubMed ID: 37246199
[TBL] [Abstract][Full Text] [Related]
37. Enhancing evaluation of sarcopenia in patients with non-small cell lung cancer (NSCLC) by assessing skeletal muscle index (SMI) at the first lumbar (L1) level on routine chest computed tomography (CT).
Recio-Boiles A; Galeas JN; Goldwasser B; Sanchez K; Man LMW; Gentzler RD; Gildersleeve J; Hollen PJ; Gralla RJ
Support Care Cancer; 2018 Jul; 26(7):2353-2359. PubMed ID: 29417293
[TBL] [Abstract][Full Text] [Related]
38. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
[TBL] [Abstract][Full Text] [Related]
39. Computed tomography-determined skeletal muscle density predicts 3-year mortality in initial-dialysis patients in China.
Sheng MJ; Cao JY; Hou SM; Li M; Wang Y; Fang Q; Miao AF; Yang M; Liu SS; Hu CH; Liu CL; Wang SY; Zheng J; Xiao JJ; Zhang XL; Liu H; Liu BC; Wang B
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2569-2578. PubMed ID: 37722854
[TBL] [Abstract][Full Text] [Related]
40. Sarcopenia: The need to establish different cutoff points of fat-free mass for the Chilean population.
Wigodski S; Carrasco F; Bunout D; Barrera G; Hirsch S; de la Maza MP
Nutrition; 2019 Jan; 57():217-224. PubMed ID: 30184515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
